Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Legend Holdings
Legend Holdings Realized Revenue of RMB436 billion in 2023
March 29, 2024
From
Legend Holdings
Via
ACN Newswire
Legend Holdings (3396.HK) Announced 2021 Annual Results
April 01, 2022
From
Legend Holdings
Via
ACN Newswire
Legend Holdings: Remaining True to the Original Aspiration, Leading by Technology, and Serving the Country through Industry
March 31, 2022
From
Legend Holdings
Via
ACN Newswire
Legend Capital Leads TuringQ's Pre-A Funding
November 12, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital leads ForQaly Medical's Series B financing
October 08, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital is reaping the rewards in its logistics and supply chain investment
September 27, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital Led a New Round of Investment of Etana
September 14, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment
September 10, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Holdings Announces 2021 Interim Results, Revenue and Net Profit Attributable to Equity Holders Recorded a Historical High
September 02, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Holdings Revenue and Net Profit Attributable to Equity Holders of the Company Stood at RMB 228.57 Billion and RMB 4.69 Billion in 1H2021
September 01, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital invests in Series A funding round of BioMap, a biological computing platform
July 30, 2021
From
Legend Holdings
Via
ACN Newswire
Legend Capital continues to be optimistic about technological innovation, with great opportunities in tech investment
July 14, 2021
From
Legend Holdings
Via
ACN Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.